SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYPB - Cypress BioScience -- Ignore unavailable to you. Want to Upgrade?

To: growthvalue who wrote (399)9/16/1998 10:34:00 PM
From: Martin Spallone  Read Replies (1) | Respond to of 586
 
To All: Cypress will not market Prosorba(R) column, American Home Products will. Thanks Joel - I owe you another one.



To: growthvalue who wrote (399)9/16/1998 11:33:00 PM
From: kathleen  Read Replies (1) | Respond to of 586
 
The rheumatologist can make more money off of it if he has the machine in his office. I think Cypress already has a partner for the machines.



To: growthvalue who wrote (399)9/17/1998 8:45:00 AM
From: John S. Baker  Read Replies (1) | Respond to of 586
 
No serious side effects noted. FWIW in any discussion of Prosorba column usage, it's useful to recall that it is intended only for use in the most serious (intractable) cases. Many of the patients in the blind tests were unable to move around except with assistance. As currently envisioned, this is a last ditch treatment.

JSb.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News